دورية أكاديمية
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma
العنوان: | Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma |
---|---|
المؤلفون: | Evans, Thomas R. Jeffry, Kudo, Masatoshi, Finn, Richard S., Han, Kwang-Hyub, Cheng, Ann-Lii, Ikeda, Masafumi, Kraljevic, Silvija, Ren, Min, Dutcus, Corina E., Piscaglia, Fabio, Sung, Max W. |
المصدر: | British Journal of Cancer ; volume 121, issue 7, page 625-625 ; ISSN 0007-0920 1532-1827 |
بيانات النشر: | Springer Science and Business Media LLC |
سنة النشر: | 2019 |
مصطلحات موضوعية: | Cancer Research, Oncology |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1038/s41416-019-0534-2 |
الإتاحة: | https://doi.org/10.1038/s41416-019-0534-2Test http://www.nature.com/articles/s41416-019-0534-2.pdfTest http://www.nature.com/articles/s41416-019-0534-2Test |
حقوق: | https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test |
رقم الانضمام: | edsbas.DC44DB1A |
قاعدة البيانات: | BASE |
DOI: | 10.1038/s41416-019-0534-2 |
---|